Moonlight Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Investors
-
9
Moonlight Therapeutics General Information
Description
Developer of intradermal therapy designed to transform the lives of people with food allergies. The company offers a small, painless intradermal stamp providing at-home administration with effective desensitization, enabling individuals with peanut allergies to reduce their risk of dangerous allergic reactions and support safer daily living.
Contact Information
Website
www.moonlighttx.comCorporate Office
- 3175 Presidential Drive
- Atlanta, GA 30340
- United States
Corporate Office
- 3175 Presidential Drive
- Atlanta, GA 30340
- United States
Moonlight Therapeutics Timeline
Moonlight Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 01-Jul-2025 | Completed | Pre-Clinical Trials | |||
| 10. Later Stage VC (Series A) | 01-Aug-2024 | Completed | Pre-Clinical Trials | |||
| 9. Grant | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 8. Grant | 02-Aug-2021 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 01-Jan-2021 | Completed | Pre-Clinical Trials | |||
| 6. Accelerator/Incubator | 01-Oct-2020 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 07-May-2019 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 01-Apr-2019 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-Jan-2019 | $651K | Completed | Pre-Clinical Trials | ||
| 2. Grant | 12-Oct-2018 | $3.3M | Completed | Pre-Clinical Trials |
Moonlight Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 | ||||||||
| Series A-3 | 1,381,064 | $0.000100 | $0.32 | $0.32 | 1x | $0.32 | 8.05% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Moonlight Therapeutics Signals
Moonlight Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IndieBio | Accelerator/Incubator | Minority | ||
| SOSV | Venture Capital | Minority | ||
| AllerFund Ventures | Venture Capital | Minority | ||
| Georgia Research Alliance | Not-For-Profit Venture Capital | Minority | ||
| Portal Innovations | Venture Capital | Minority |
Moonlight Therapeutics FAQs
-
When was Moonlight Therapeutics founded?
Moonlight Therapeutics was founded in 2017.
-
Where is Moonlight Therapeutics headquartered?
Moonlight Therapeutics is headquartered in Atlanta, GA.
-
What is the size of Moonlight Therapeutics?
Moonlight Therapeutics has 6 total employees.
-
What industry is Moonlight Therapeutics in?
Moonlight Therapeutics’s primary industry is Drug Discovery.
-
Is Moonlight Therapeutics a private or public company?
Moonlight Therapeutics is a Private company.
-
What is Moonlight Therapeutics’s current revenue?
The current revenue for Moonlight Therapeutics is .
-
How much funding has Moonlight Therapeutics raised over time?
Moonlight Therapeutics has raised $2.42M.
-
Who are Moonlight Therapeutics’s investors?
IndieBio, SOSV, AllerFund Ventures, Georgia Research Alliance, and Portal Innovations are 5 of 9 investors who have invested in Moonlight Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process